David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared Conveners’s post on LinkedIn, adding:
“Many thanks to my UAE colleagues and friends for the invitation EOS, the warm welcome, and the high-quality scientific exchanges on EGFRm NSCLC. New standards like FLAURA2 have set a high bar – a new summit that will be hard to top! Looking forward to the next 10 years of innovation.”
Quoting Conveners’s post:
“Join EOS for an impactful meeting on Redefining the New Standard in the Management of EGFRm NSCLC
This meeting brings together leading oncology experts and distinguished speakers from across the world to discuss the latest advancements, clinical evidence, and evolving strategies shaping the future of EGFRm NSCLC management, fostering collaboration, innovation, and excellence in patient care.
Date: Friday, 13 February 2026
Time: 07:30 PM – 10:30 PM
Venue: Grand Plaza Mövenpick
Moderators:
Dr. Hassan Jaafar | Dr. Emad Dawoud
Panelists:
Prof. David Planchard
Dr. Saeed Rafii
Dr. Fathi Azribi
Dr. Muath Alnassar
Dr. Dalia Elshorbagy
Dr. Dina Hamza
Dr. Abdulrahman Zar
Dr. Abdulaziz AlJassim
Dr. Amin Abyad
Dr. Maroun Khoury
Endorsed by: Emirates Oncology Society
Sponsored by: AstraZeneca
Managed by: Conveners
Don’t miss this opportunity to connect with global leaders in oncology, exchange insights, and redefine standards of care together”
Other articles featuring David Planchard and Conveners on OncoDaily.
